Androgen receptor profiling predicts prostate cancer outcome

Publisher： John Wiley & Sons Inc

E-ISSN： 1757-4684|7|11|1450-1464

ISSN： 1757-4676

Source： EMBO Molecular Medicine, Vol.7, Iss.11, 2015-11, pp. : 1450-1464

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Divergent androgen regulation of unfolded protein response pathways drives prostate cancer

By  

EMBO Molecular Medicine, Vol. 7, Iss. 6, 2015-06 ,pp. : 788-801

John Wiley & Sons Inc

Access to resources Recommend Favorite

Apigenin suppresses insulin‐like growth factor I receptor signaling in human prostate cancer: An in vitro and in vivo study

By  

Molecular Carcinogenesis, Vol. 48, Iss. 3, 2009-03 ,pp. : 243-252

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circadian genes and risk of prostate cancer in the prostate cancer prevention trial

By  

Molecular Carcinogenesis, Vol. 57, Iss. 3, 2018-03 ,pp. : 462-466

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prostate Cancer Disparities throughout the Cancer Control Continuum

By Borysova Meghan E.   Sultan Dawood H.   Chornokur Ganna   Dalton Kyle J.   Troutman Adewale  

Social Sciences, Vol. 2, Iss. 4, 2013-11 ,pp. : 247-269

MDPI

Access to resources Recommend Favorite

Increased androgen receptor gene copy number is associated with TMPRSS2‐ERG rearrangement in prostatic small cell carcinoma

By  

Molecular Carcinogenesis, Vol. 54, Iss. 9, 2015-09 ,pp. : 900-907

John Wiley & Sons Inc

Access to resources Recommend Favorite